A Phase 1 Study of CG001419 Administered Orally in Healthy Subjects

NCT06636500 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer Study
Pain Management

Interventions

DRUG: CG001419
DRUG: Placebo

Sponsor

Cullgen Australia Pty Ltd